65
Participants
Start Date
January 29, 2024
Primary Completion Date
January 31, 2026
Study Completion Date
February 1, 2027
Celecoxib
In Phase I twenty (20) children will receive either celecoxib 14 or 7 mg/kg 120-180 minutes prior to lumbar puncture (LP). In Phase II forty-five (45) children will receive celecoxib 14 mg/kg, 7 mg/kg or placebo in one of 5 time intervals, 1-24 hours prior to LP.
Placebo
In Phase II forty-five (45) children will receive celecoxib 14 mg/kg, 7 mg/kg or placebo in one of 5 time intervals, 1-24 hours prior to LP.
RECRUITING
Children's Hospital of Eastern Ontario, Ottawa
Children's Hospital of Eastern Ontario
OTHER